Key facts
- This page summarizes Athanasios Skarpelos's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 04 Apr 2023, 17:30.
Athanasios Skarpelos - 31 Mar 2023 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Issuer symbol
- AVXL
- Transactions as of
- 31 Mar 2023
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 04 Apr 2023, 17:30:31 UTC
- Previous filing
- 29 Jun 2022
- Next filing
- 23 Feb 2024
- SEC filing
- View on sec.gov
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Athanasios Skarpelos filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 04 Apr 2023.
Change
- Previous filing in this sequence was filed on 29 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
AVXL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 31 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $8.57
- Footnotes
- F1
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Options vest in equal instalments over three years from the grant date |